ArticleCancers2020

On-Treatment Changes in FIB-4 and 1-Year FIB-4 Values Help Identify Patients with Chronic Hepatitis B Receiving Entecavir Therapy Who Have the Lowest Risk of Hepatocellular Carcinoma.

Hung-Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.